» Articles » PMID: 30582654

DANCR-mediated MicroRNA-665 Regulates Proliferation and Metastasis of Cervical Cancer Through the ERK/SMAD Pathway

Overview
Journal Cancer Sci
Specialty Oncology
Date 2018 Dec 25
PMID 30582654
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidence has indicated that microRNAs (miRNAs) play an important role in cervical cancer (CC). However, the role of miRNA (miR)-665 in cervical cancer remains unclear. The aim of the present study was to investigate the potential functions of miR-665 in CC and to identify the underlying mechanisms of action. Herein, we show that miR-665 was downregulated in CC tissues and cell lines, which is negatively correlated with tumor size, distant metastasis, advanced TNM stage and poor prognosis. Functionally, miR-665 inhibited cell proliferation, migration and invasion and resistance of cisplatin for CC cells, as well as tumor growth. We validated that transforming growth factor beta receptor 1 (TGFBR1) was a direct target of miR-665 and mediated the ERK/SMAD pathway. In addition, we identified miR-665 as the competing endogenous RNA for long noncoding (lnc)-DANCR. These observations suggested that lnc-DANCR-mediated miR-665 downregulation regulates the malignant phenotype of CC cells by targeting TGFBR1 through the ERK/SMAD pathway, which may present a pathway for novel therapeutic stratagems for CC therapy.

Citing Articles

LncRNA DANCR-V1 is a novel regulator of Wnt/β-catenin and TGF-β1/SMAD signaling pathways in colorectal cancer: an in vitro and in silico study.

Hosseini Farzad S, Lashkarboloki M, Mowla S, Soltani B Mol Biol Rep. 2024; 52(1):36.

PMID: 39643825 DOI: 10.1007/s11033-024-10128-0.


Integrated analysis of N6-methyladenosine- and 5-methylcytosine-related long non-coding RNAs for predicting prognosis in cervical cancer.

Gao J, Zhang X, Xu A, Li W, Gao H Hereditas. 2024; 161(1):34.

PMID: 39285452 PMC: 11403863. DOI: 10.1186/s41065-024-00336-w.


New evidence for a role of DANCR in cancers: a comprehensive review.

Yuan R, Xu Z, Zhang S, Cao X, Dai A, Song L J Transl Med. 2024; 22(1):569.

PMID: 38877534 PMC: 11177382. DOI: 10.1186/s12967-024-05246-z.


HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer.

Li X, Zheng Z, Zhou W, Huang H, Zhou Y, Xu Q J Ovarian Res. 2024; 17(1):124.

PMID: 38851728 PMC: 11161928. DOI: 10.1186/s13048-024-01424-1.


Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer.

Safavi P, Moghadam K, Haghighi Z, Ferns G, Rahmani F Curr Pharm Des. 2024; 30(5):352-361.

PMID: 38303530 DOI: 10.2174/0113816128284380240123071409.


References
1.
Guo J, Yang Z, Yang X, Li T, Liu M, Tang H . miR-346 functions as a pro-survival factor under ER stress by activating mitophagy. Cancer Lett. 2017; 413:69-81. DOI: 10.1016/j.canlet.2017.10.030. View

2.
Li H, Jia Y, Cheng J, Liu G, Song F . LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway. Cell Death Dis. 2018; 9(2):198. PMC: 5833418. DOI: 10.1038/s41419-017-0249-3. View

3.
Zhou B, Guo W, Sun C, Zhang B, Zheng F . Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell Death Dis. 2018; 9(6):706. PMC: 5999603. DOI: 10.1038/s41419-018-0724-5. View

4.
Lee R, Feinbaum R, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5):843-54. DOI: 10.1016/0092-8674(93)90529-y. View

5.
Liu J, Jiang Y, Wan Y, Zhou S, Thapa S, Cheng W . MicroRNA‑665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10. Mol Med Rep. 2018; 18(3):2661-2668. PMC: 6102655. DOI: 10.3892/mmr.2018.9252. View